Cardiovascular Health And Risk Modification in Family Health Teams

Hypertension Clinical Trial

— Multi-CHARM  

Official title:

Multidisciplinary Cardiovascular Health And Risk Modification in Family Health Teams

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00787306
• Other study ID #: MOH-1048
• Status: Completed
• Phase: Phase 3
• First received: November 6, 2008
• Last updated: March 31, 2018
• Start date: October 2008
• Est. completion date: June 2009

Study information

• Verified date: March 2018
• Source: University of Toronto
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Cardiovascular diseases remain the main cause of mortality in Canada. While effective interventions are available for reducing the risk of cardiovascular disease,there continue to be gaps between the potential reduction in risk that could be achieved by effectively managing these risk factors and levels of risk factor control currently in clinical practice. This study will evaluate the ability of a different model of risk factor care using other health providers assisting family doctors, along with information aids for patients and health professionals,to achieve better levels of cardiovascular risk factor control in adults.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 229
• Est. completion date: June 2009
• Est. primary completion date: June 2009
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 50 Years to 80 Years

Eligibility

Inclusion Criteria:

• adults 50 to 80 years of age

• having attending a family medicine clinic for more than one year

Exclusion Criteria:

• not able to participate for one year

• not able to read English

• requires house calls

• nursing home resident

• cognitive impairment

• current chest pain or symptoms of active coronary heart disease

Related Conditions & MeSH terms

• Cardiovascular Risk Factors
• Diabetes
• Hyperlipidemia
• Hyperlipidemias
• Hyperlipoproteinemias
• Hypertension

Intervention

Behavioral:
• Active risk factor surveillance
Cardiovascular risk status assessment followed by active surveillance and physician review where risk factor control is suboptimal

Locations

Country	Name	City	State
Canada	Granovsky Gluskin Family Medicine Cwntre	Toronto	Ontario

Sponsors (1)

Lead Sponsor	Collaborator
University of Toronto

Country where clinical trial is conducted

Canada, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	mean systolic blood pressure		6 months
Secondary	Proportion of adults with 3 cardiovascular risk factors under optimal control		6 months